Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cardiol Therapeutics (TSE:CRDL)
TSX:CRDL
RESEARCH TOOLSreports
Holding TSE:CRDL?
Track your performance easily
Cardiol Therapeutics (CRDL) Ownership Overview
5.27% Insiders
0.06% Mutual Funds
5.46% Other Institutional Investors
1.49% ETFs
87.71% Public Companies and
Individual Investors
The ownership structure of Cardiol Therapeutics (TSE:CRDL) stock is a mix of institutional, retail, and individual investors. Approximately 7.01% of the company’s stock is owned by Institutional Investors, 5.27% is owned by Insiders, and 87.71% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 19, 2024 | Peter Pekos Non Executive,director | xxxxxxxxxxxxx | $49968 |
| Dec 18, 2024 | David Elsley President & Chief Executive Officer | xxxxxxxxxxxxx | C$75072 |
| Dec 18, 2024 | Christopher James Waddick Chief Financial Officer | xxxxxxxxxxxxx | C$49702 |
| Dec 18, 2024 | Bernard Lim Chief Operating Officer | xxxxxxxxxxxxx | C$19500 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,244,500 | Insider | 1.53% | 1,624,073 | |
| 1,012,080 | Insider | 1.24% | 1,320,764 | |
| 877,358 | Institution | 1.08% | 1,144,952 | |
| 840,580 | Insider | 1.03% | 1,096,957 | |
| 447,713 | Insider | 0.55% | 584,265 | |
| 291,117 | Institution | 0.36% | 379,908 | |
| 220,521 | Insider | 0.27% | 287,780 | |
| 142,500 | Insider | 0.17% | 185,963 | |
| 135,900 | Insider | 0.17% | 177,350 | |
| 120,000 | Insider | 0.15% | 156,600 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 52,435 | Institution | 0.06% | 68,428 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 877,358 | Institution | 1.08% | 1,123,018 | |
| 46,238 | Institution | 0.06% | 87,390 |
FAQ
Who Owns Cardiol Therapeutics (TSE:CRDL)?
According to the latest TipRanks data, approximately 5.46% of the company's stock is held by institutional investors, 5.27% is held by insiders, and 87.71% is held by retail investors.
What percentage of Cardiol Therapeutics (TSE:CRDL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 5.46% of Cardiol Therapeutics (TSE:CRDL) stock is held by institutional investors.
What percentage of Cardiol Therapeutics (TSE:CRDL) stock is held by retail investors?
According to the latest TipRanks data, approximately 87.71% of Cardiol Therapeutics (TSE:CRDL) stock is held by retail investors.
Who owns the most shares of Cardiol Therapeutics (TSE:CRDL)?
David Elsley owns the most shares of Cardiol Therapeutics (TSE:CRDL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.